Moderna | MRNA - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 270.12M 2.55M 2026-06
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Alnylam Pharmaceuticals USD 1.06B 160.97M 2026-06
Amgen USD 11.69B 6.9B 2026-06
Arrowhead Research USD 245.35M 30.35M 2026-06
Biogen USD 2.98B 1.02B 2026-06
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Celltrion KRW 119.22B 21.46B 2026-03
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Incyte USD 973.64M 4.65B 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 960M 817M 2026-06
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 173K 990K 2025-12
Pharma Mar EUR 51.01M 8.73M 2026-06
Puma Biotechnology USD 49.26M 3.2M 2024-06
Qiagen NV USD 393.64M 17.95M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
Sartorius EUR 747.8M 9.4M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tilray USD 237.52M 17.34M 2025-09
Ultragenyx Pharmaceutical USD 289M 16M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03